3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
18
Hematologic Neoplasms
14
Leukemia
13
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Uterine Cervical Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Breast Neoplasms
2
Blast Crisis
2
Virus Diseases
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Recurrence
1
Pyruvate Kinase Deficiency of Red Cells
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Interventions
Polymerase Chain Reaction
3
Flow Cytometry
3
Ganciclovir
2
Valganciclovir
1
VCL-CB01 vaccine
1
Therapeutics
1
Peripheral Blood Stem Cell Transplantation
1
Immunologic Techniques
1
Foscarnet
1
Blood Specimen Collection
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytomegalovirus Infections
×
Blood Specimen Collection
×
Other hematologic neoplasm
×
Clear all
NCT03806764
2023-06-01
CReSCT
Melbourne Health
Phase NA
Unknown
370 enrolled